Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

3.33
Delayed Data
As of Apr 28
 +0.05 / +1.52%
Today’s Change
2.83
Today|||52-Week Range
7.51
-18.38%
Year-to-Date

Today’s Trading

Previous close3.28
Today’s open3.29
Day’s range3.26 - 3.33
Volume871,075
Average volume (3 months)3,085,218
Market cap$428.3M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+9.02%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+61.64%
P/E ratioNM
Price/Sales3.54
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...+0.01+0.10%
ARNAArena Pharmaceutical...-0.04-2.90%
TLGTTeligent Inc-0.08-1.00%
SCMPSucampo Pharmaceutic...+0.05+0.50%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$144.3M
Annual profit (last year)-$151.7M
Net profit margin-105.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Richard Peters
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts